Jonathan Oliver

Jonathan Oliver, MBA, currently serves as Key Account Manager at Precigen since September 2025, leading the launch of an innovative nonreplicating viral vector-based immunotherapy for recurrent respiratory papillomatosis. Previously, Jonathan held multiple roles at AstraZeneca from October 2019 to June 2025, including Associate Director of Marketing for Immuno-Oncology Lung and Senior Marketing Manager for EGFR Lung Cancer, where responsibilities included leading marketing strategies for early-stage lung indications and developing brand strategies for metastatic EGFRm NSCLC. Jonathan's earlier experience at Astellas Pharma from October 2006 to October 2019 involved launching the Key Account Management function for the Health Systems Business Unit, focusing on oncology, and developing sales strategies in the urology and primary care sectors. Earlier roles at PDI, Inc. included responsibilities as a Respiratory Sales Specialist. Jonathan holds an MBA with honors from The George Washington University School of Business and a B.S. in Biology/Biotechnology/Biobusiness from Virginia Tech.